Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash & Current Investments (2019 - 2025)

Burning Rock Biotech has reported Cash & Current Investments over the past 7 years, most recently at $67.8 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 6.69% year-over-year to $67.8 million; the TTM value through Dec 2025 reached $67.8 million, down 6.69%, while the annual FY2025 figure was $67.8 million, 5.6% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $67.8 million at Burning Rock Biotech, up from $65.7 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $330.2 million in Q1 2021 and troughed at $63.2 million in Q2 2025.
  • A 5-year average of $135.9 million and a median of $96.4 million in 2023 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: surged 532.21% in 2021 and later plummeted 44.33% in 2023.
  • Year by year, Cash & Current Investments stood at $225.1 million in 2021, then plummeted by 42.2% to $130.1 million in 2022, then tumbled by 34.32% to $85.4 million in 2023, then dropped by 14.92% to $72.7 million in 2024, then dropped by 6.69% to $67.8 million in 2025.
  • Business Quant data shows Cash & Current Investments for BNR at $67.8 million in Q4 2025, $65.7 million in Q3 2025, and $63.2 million in Q2 2025.